Rare Liver Cancer Decoded: Groundbreaking Clinical Trial Begins

Rare Liver Cancer Decoded: Groundbreaking Clinical Trial Begins

FLC is a rare liver cancer with unique genetic traits, often misdiagnosed until advanced. New research and a clinical trial offer hope for effective treatments. Fibrolamellar hepatocellular carcinoma (FLC), like many rare diseases, strikes a small but vulnerable group—primarily children, adolescents, and young adults—with devastating impact. Its symptoms vary widely between individuals, often leading to [...]

Research using non-toxic bacteria to fight high-mortality cancers prepares for clinical trials - Scientific Inquirer

A University of Massachusetts Amherst-Ernest Pharmaceuticals team of scientists has made “exciting,” patient-friendly advances in developing a non-toxic bacterial therapy, BacID, to deliver cancer-fighting drugs directly into tumors. This emerging technology holds promise for very safe and more effective treatment of cancers with high mortality rates, including liver, ovarian and metastatic breast cancer. Clinical trials with participating cance…

Research Using Non-Toxic Bacteria to Fight High-Mortality Cancers Prepares for Clinical Trials

The latest breakthrough from a team of UMass Amherst and Ernest Pharmaceutical researchers uses aspirin in its targeted drug delivery therapy.